480 related articles for article (PubMed ID: 18931277)
21. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
22. AIDS related Kaposi's sarcoma presenting with palatal and eyelid nodule.
Joshi U; Ceena DE; Ongole R; Sumanth KN; Boaz K; Jeena Priy K; Srikan N
J Assoc Physicians India; 2012 Jul; 60():50-3. PubMed ID: 23405543
[TBL] [Abstract][Full Text] [Related]
23. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
Bower M; Nelson M; Young AM; Thirlwell C; Newsom-Davis T; Mandalia S; Dhillon T; Holmes P; Gazzard BG; Stebbing J
J Clin Oncol; 2005 Aug; 23(22):5224-8. PubMed ID: 16051964
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
26. How does HAART lead to the resolution of Kaposi's sarcoma?
Stebbing J; Portsmouth S; Gazzard B
J Antimicrob Chemother; 2003 May; 51(5):1095-8. PubMed ID: 12668573
[No Abstract] [Full Text] [Related]
27. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
[TBL] [Abstract][Full Text] [Related]
28. Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral therapy.
Kawsar M
Int J STD AIDS; 2005 Aug; 16(8):582-3; author reply 583. PubMed ID: 16105195
[No Abstract] [Full Text] [Related]
29. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
30. Case report: Kaposi's sarcoma: an unusual presentation.
Young AC; Mazzullo JM; Simon AR; Skolnik PR
MedGenMed; 2001 Sep; 3(4):8. PubMed ID: 11698915
[TBL] [Abstract][Full Text] [Related]
31. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.
Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P
Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327
[TBL] [Abstract][Full Text] [Related]
32. Peculiar type of KS emerges in healthier individuals.
Proj Inf Perspect; 2008 Dec; (47):13-4. PubMed ID: 19230234
[No Abstract] [Full Text] [Related]
33. Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India.
Umadevi KM; Ranganathan K; Pavithra S; Hemalatha R; Saraswathi TR; Kumarasamy N; Solomon S; Greenspan JS
J Oral Pathol Med; 2007 Mar; 36(3):136-41. PubMed ID: 17305634
[TBL] [Abstract][Full Text] [Related]
34. [Leishmanial parasitation of Kaposi's sarcoma in a HIV patient].
Hinojosa MC; González MI; Martínez G; Ginés A
Rev Esp Quimioter; 2011 Mar; 24(1):54-5. PubMed ID: 21412673
[No Abstract] [Full Text] [Related]
35. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma in a nonadherent HAART patient.
Ball SC
AIDS Read; 1999; 9(3):170, 173-4. PubMed ID: 12728902
[No Abstract] [Full Text] [Related]
37. Kaposi's sarcoma, lymphoedema and gangrene in AIDS--a therapeutic challenge.
Ebrahim S; Singh B; Moodley J; Ramdial PK
S Afr J Surg; 2009 May; 47(2):62-3. PubMed ID: 19626783
[No Abstract] [Full Text] [Related]
38. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
39. Different impact of anti-retroviral regimen containing protease inhibitors on development of HIV-related Kaposi sarcoma.
Carleo MA; Di Martino F; Del Giudice A; Gargiulo M; Parrella G; Rosario P; Sangiovanni V; Viglietti R; Esposito V; Chirianni A
In Vivo; 2015; 29(1):133-6. PubMed ID: 25600542
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report.
Feller L; Anagnostopoulos C; Wood NH; Bouckaert M; Raubenheimer EJ; Lemmer J
J Periodontol; 2008 Feb; 79(2):362-8. PubMed ID: 18251652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
